Christy Cappelletti
AstraZeneca
24 Papers
38 Citations
Christy Cappelletti is an academic researcher from AstraZeneca. The author has contributed to research in topics: Medicine & Asthma. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
Alberto Papi,Bradley E. Chipps,Richard Beasley,Reynold A. Panettieri,Elliot Israel,Mark Cooper,L. Dunsire,Allison Jeynes-Ellis,Eva Johnsson,Robert Rees,Christy Cappelletti,Frank C. Albers +11 more
TL;DR: The risk of severe asthma exacerbation was significantly lower with as-needed use of a fixed-dose combination of 180 μg of albuterol and 160 μg of budesonide than with as the needed use of al buterol alone among patients with uncontrolled moderate-to-severe asthma who were receiving a wide range of inhaled glucocorticoid-containing maintenance therapies.
46
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study
Gary T. Ferguson,Alberto Papi,Antonio Anzueto,Edward Kerwin,Christy Cappelletti,Elizabeth A. Duncan,Jack Nyberg,Paul Dorinsky +7 more
TL;DR: BFF MDI improved lung function versus monocomponents and exacerbations versus FF MDI in patients with moderate to very severe COPD, without a requirement for an exacerbation history.
23
Reaching Beyond Disparity: Safely Improving Asthma Control in the At-Risk African-American Population
TL;DR: Overall, evidence suggests that if African- American patients with asthma are provided with access to well-trained physicians, appropriate asthma management and effective medications, existing disparities in asthma control between African-American and white populations may be overcome.
11
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study
Craig LaForce,Bradley E. Chipps,Frank C. Albers,Laurence Reilly,Eva Johnsson,Helen Andrews,Christy Cappelletti,Andrea Maes,Alberto Papi +8 more
TL;DR: In this paper, a randomized, double-blind, 2-period, single-dose crossover study was conducted to assess the efficacy and safety of albuterol/budesonide compared with placebo in patients with asthma and exercise-induced bronchoconstriction.
8
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials
Christy Cappelletti,Andrea Maes,Kimberly Rossman,Michael Gillen,Craig LaForce,Edward Kerwin,Colin Reisner +6 more
TL;DR: In this article, the authors evaluated the efficacy and safety of albuterol sulfate inhalation suspension via metered-dose inhaler (AS MDI, PT007) in patients with persistent asthma.